Cao Zhang AM - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Emerging clinical role of proprotein convertase subtilisin/kexin type 9 inhibition-Part one: Pleiotropic pro-atherosclerotic effects of PCSK9.

Cao Zhang AM, Ziogos E, Harb T, Gerstenblith G, Leucker TM. Cao Zhang AM, et al. Eur J Clin Invest. 2024 Oct;54(10):e14273. doi: 10.1111/eci.14273. Epub 2024 Jun 26. Eur J Clin Invest. 2024. PMID: 38922860 Review.

Emerging clinical role of proprotein convertase subtilisin/kexin type 9 inhibition-Part two: Current and emerging concepts in the clinical use of PCSK9 inhibition.

Cao Zhang AM, Ziogos E, Harb T, Gerstenblith G, Leucker TM. Cao Zhang AM, et al. Eur J Clin Invest. 2024 Oct;54(10):e14272. doi: 10.1111/eci.14272. Epub 2024 Jun 26. Eur J Clin Invest. 2024. PMID: 38924090 Review.

Concomitant oxidative haemolysis and methaemoglobinaemia following inhaled nitric oxide in a patient with G6PD deficiency.

Cao Zhang AM, Zale AD, Tabbara N, Yui JC. Cao Zhang AM, et al. BMJ Case Rep. 2024 Aug 29;17(8):e259709. doi: 10.1136/bcr-2024-259709. BMJ Case Rep. 2024. PMID: 39209743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters